Locust Wood Capital Advisers, LLC Abbott Laboratories Transaction History

Locust Wood Capital Advisers, LLC

$2.4 Billion
Q2 2024

A detailed history of Locust Wood Capital Advisers, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Locust Wood Capital Advisers, LLC holds 232,300 shares of ABT stock, worth $26.1 Million. This represents 1.0% of its overall portfolio holdings.

Number of Shares

232,300

Previous 232,300 -0.0%

Holding current value

$26.1 Million

Previous $26.4 Million 8.58%

% of portfolio

1.0%

Previous 1.11%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$100.73 - $112.44 $2.28 Million - $2.55 Million	22,673 Added 2.43%	956,453 $99.4 Million
Q1 2024 May 08, 2024	SELL	$109.52 - $120.96 $11.5 Million - $12.7 Million	-105,084 Reduced 10.12%	933,780 $106 Million
Q4 2023 Feb 07, 2024	BUY	$90.19 - $110.4 $8.45 Million - $10.3 Million	93,701 Added 9.91%	1,038,864 $114 Million
Q3 2023 Nov 08, 2023	BUY	$95.53 - $114.62 $28 Million - $33.6 Million	293,479 Added 45.03%	945,163 $91.5 Million
Q2 2023 Aug 08, 2023	BUY	$100.78 - $112.29 $5.41 Million - $6.03 Million	53,709 Added 8.98%	651,684 $71 Million
Q1 2023 May 05, 2023	BUY	$96.86 - $114.01 $28.1 Million - $33 Million	289,723 Added 93.99%	597,975 $60.6 Million
Q4 2022 Jan 30, 2023	SELL	$95.06 - $111.52 $11.5 Million - $13.5 Million	-121,475 Reduced 28.27%	308,252 $33.8 Million
Q3 2022 Nov 01, 2022	BUY	$96.76 - $112.03 $1.49 Million - $1.73 Million	15,408 Added 3.72%	429,727 $41.6 Million
Q2 2022 Jul 20, 2022	BUY	$102.07 - $123.37 $12.8 Million - $15.4 Million	124,936 Added 43.17%	414,319 $45 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $10.8 Million - $13.2 Million	-94,702 Reduced 24.66%	289,383 $34.3 Million
Q4 2021 Jan 24, 2022	BUY	$115.53 - $141.46 $419,373 - $513,499	3,630 Added 0.95%	384,085 $54.1 Million
Q3 2021 Oct 20, 2021	BUY	$116.66 - $129.06 $365,379 - $404,215	3,132 Added 0.83%	380,455 $44.9 Million
Q2 2021 Jul 26, 2021	BUY	$105.79 - $124.53 $10.1 Million - $11.9 Million	95,377 Added 33.83%	377,323 $43.7 Million
Q1 2021 Apr 22, 2021	BUY	$108.84 - $128.23 $5.27 Million - $6.21 Million	48,436 Added 20.74%	281,946 $33.8 Million
Q4 2020 Jan 25, 2021	BUY	$105.0 - $114.42 $4.76 Million - $5.18 Million	45,310 Added 24.08%	233,510 $25.6 Million
Q3 2020 Oct 21, 2020	SELL	$91.64 - $111.29 $2.87 Million - $3.48 Million	-31,305 Reduced 14.26%	188,200 $20.5 Million
Q2 2020 Jul 21, 2020	SELL	$76.57 - $98.0 $3.09 Million - $3.96 Million	-40,411 Reduced 15.55%	219,505 $20.1 Million
Q1 2020 May 05, 2020	SELL	$62.82 - $91.86 $1.43 Million - $2.09 Million	-22,780 Reduced 8.06%	259,916 $20.5 Million
Q4 2019 Jan 28, 2020	SELL	$78.51 - $87.4 $13.9 Million - $15.4 Million	-176,600 Reduced 38.45%	282,696 $24.6 Million
Q3 2019 Oct 22, 2019	SELL	$81.84 - $88.74 $8.59 Million - $9.31 Million	-104,930 Reduced 18.6%	459,296 $38.4 Million
Q2 2019 Jul 24, 2019	SELL	$72.88 - $85.0 $11.5 Million - $13.4 Million	-157,940 Reduced 21.87%	564,226 $47.5 Million
Q1 2019 Apr 16, 2019	SELL	$66.22 - $80.06 $4.1 Million - $4.96 Million	-61,980 Reduced 7.9%	722,166 $57.7 Million
Q4 2018 Feb 01, 2019	BUY	$65.56 - $74.27 $7.66 Million - $8.68 Million	116,885 Added 17.52%	784,146 $56.7 Million
Q3 2018 Nov 05, 2018	SELL	$60.81 - $73.36 $9.38 Million - $11.3 Million	-154,333 Reduced 18.78%	667,261 $49 Million
Q2 2018 Aug 09, 2018	SELL	$57.57 - $63.54 $4.93 Million - $5.44 Million	-85,612 Reduced 9.44%	821,594 $50.1 Million
Q1 2018 Apr 18, 2018	BUY	$56.27 - $63.62 $5.56 Million - $6.28 Million	98,750 Added 12.21%	907,206 $54.4 Million
Q4 2017 Jan 30, 2018	SELL	$53.68 - $57.47 $69,247 - $74,136	-1,290 Reduced 0.16%	808,456 $46.1 Million
Q3 2017 Oct 18, 2017	BUY	$48.06 - $53.64 $38.9 Million - $43.4 Million	809,746	809,746 $43.2 Million

Others Institutions Holding ABT

# of Institutions

3,135

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Locust Wood Capital Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Locust Wood Capital Advisers, LLC with notifications on news.

Account

Locust Wood Capital Advisers, LLC Abbott Laboratories Transaction History